McDevitt William M, Rowberry Tracey A, Davies Paul, Bill Peter R, Notghi Lesley M, Morris Kevin P, Scholefield Barnaby R
Department of Neurophysiology, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom.
Paediatric Intensive Care Unit, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom.
J Clin Neurophysiol. 2021 Jan 1;38(1):30-35. doi: 10.1097/WNP.0000000000000649.
Absent cortical somatosensory evoked potentials (SSEPs) reliably predict poor neurologic outcome in adults after cardiac arrest (CA). However, there is less evidence to support this in children. In addition, targeted temperature management, test timing, and a lack of blinding may affect test accuracy.
A single-center, prospective cohort study of pediatric (aged 24 hours to 15 years) patients in which prognostic value of SSEPs were assessed 24, 48, and 72 hours after CA. Targeted temperature management (33-34°C for 24 hours) followed by gradual rewarming to 37°C was used. Somatosensory evoked potentials were graded as present, absent, or indeterminate, and results were blinded to clinicians. Neurologic outcome was graded as "good" (score 1-3) or "poor" (4-6) using the Pediatric Cerebral Performance Category scale 30 days after CA and blinded to SSEP interpreter.
Twelve patients (median age, 12 months; interquartile range, 2-150; 92% male) had SSEPs interpreted as absent (6/12) or present (6/12) <72 hours after CA. Outcome was good in 7 of 12 patients (58%) and poor in 5 of 12 patients (42%). Absent SSEPs predicted poor outcome with 88% specificity (95% confidence interval, 53% to 98%). One patient with an absent SSEP had good outcome (Pediatric Cerebral Performance Category 3), and all patients with present SSEPs had good outcome (specificity 100%; 95% confidence interval, 51% to 100%). Absence or presence of SSEP was consistent across 24-hour (temperature = 34°C), 48-hour (t = 36°C), and 72-hour (t = 36°C) recordings after CA.
Results support SSEP utility when predicting favorable outcome; however, predictions resulting in withdrawal of life support should be made with caution and never in isolation because in this very small sample there was a false prediction of unfavorable outcome. Further prospective, blinded studies are needed and encouraged.
皮层体感诱发电位(SSEPs)缺失可可靠预测成人心脏骤停(CA)后的不良神经学预后。然而,在儿童中支持这一观点的证据较少。此外,目标温度管理、测试时机以及缺乏盲法可能会影响测试准确性。
一项针对儿科(年龄24小时至15岁)患者的单中心前瞻性队列研究,在CA后24、48和72小时评估SSEPs的预后价值。采用目标温度管理(33 - 34°C持续24小时),随后逐渐复温至37°C。体感诱发电位分为存在、缺失或不确定,结果对临床医生采用盲法。使用儿科脑功能表现分类量表在CA后30天对神经学预后进行分级,分为“良好”(评分1 - 3)或“不良”(4 - 6),且对SSEP解释者采用盲法。
12例患者(中位年龄12个月;四分位间距2 - 150;92%为男性)在CA后<72小时SSEPs被解释为缺失(6/12)或存在(6/12)。12例患者中有7例(58%)预后良好,5例(42%)预后不良。SSEPs缺失预测不良预后的特异性为88%(95%置信区间,53%至98%)。1例SSEPs缺失的患者预后良好(儿科脑功能表现分类3级),所有SSEPs存在的患者预后均良好(特异性100%;95%置信区间,51%至100%)。CA后24小时(温度 = 34°C)、48小时(温度 = 36°C)和72小时(温度 = 36°C)记录的SSEPs缺失或存在情况一致。
结果支持SSEPs在预测良好预后方面的效用;然而,对于导致撤除生命支持的预测应谨慎做出,且绝不应孤立进行,因为在这个非常小的样本中存在对不良预后的错误预测。需要并鼓励进一步开展前瞻性、盲法研究。